Global Antibody Drug Conjugate Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
- Published Date: 2020-12-28
- Report ID: 35105
- Pages: 114
-
Format:
Summary
This study analysis was given on a worldwide scale, for instance, present and historical Antibody Drug Conjugate growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of Antibody Drug Conjugate production, Antibody Drug Conjugate revenue, Antibody Drug Conjugate consumption and Antibody Drug Conjugate price.
According to the current situation, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. Prudent Markets published a report for global Antibody Drug Conjugate market in this environment.
In terms of revenue, this research report indicated that the global Antibody Drug Conjugate market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Antibody Drug Conjugate industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the production and revenue data in each of the sub-segments.
The Bayer AG aims at producing XX Antibody Drug Conjugate in 2020, with XX % production to take place in global market, Concortis Biotherapeutics accounts for a volume share of XX %.
At the upcoming analysis, this report discusses industrial policy, economic environment, in addition to the COVID-19 impact and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Antibody Drug Conjugate Market by Prudent Markets Include
NorthAmerica
Asia
Europe
Middle East & Africa
South America
Competitive Analysis; Who are the Major Players in Antibody Drug Conjugate Market
Bayer AG
Concortis Biotherapeutics
F. Hoffman-La Roche Ltd.
Immunomedics, Inc.
Oxford BioTherapeutics
Pfizer Inc.
Seattle Genetics, Inc.
Takeda Pharmaceutical Company Limited
Abbvie Inc.
Astellas Pharma/Agensys
Oxford BioTherapeutics
Agensys, Inc.
Antikor
Celldex Therapeutics
Genentech
Heidelberg Pharma
Immunomedics
Mersana Therapeutics
Millennium Pharmaceuticals
Progenics Pharmaceuticals
Roche Holding Ag
Synthon
Major Type of Antibody Drug Conjugate Covered in Prudent Markets report:
Monoclonal Antibodies
Linker
Drug/Toxin
Others
Application Segments Covered in Prudent Markets Market
Blood Cancer
Breast Cancer
Ovarian Cancer
Lung Cancer
Brain Tumor
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Antibody Drug Conjugate Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Monoclonal Antibodies -Product Introduction and Major Manufacturers
1.1.2 Linker -Product Introduction and Major Manufacturers
1.1.3 Drug/Toxin -Product Introduction and Major Manufacturers
1.1.4 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2019-2026)
2.2 Regional Market Share in Terms of Revenue (2019-2026)
2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Antibody Drug Conjugate Market Assessment by Type
3.1 Global Antibody Drug Conjugate Production by Type (2015-2026)
3.2 Global Antibody Drug Conjugate Revenue by Type (2015-2026)
3.3 North America Antibody Drug Conjugate Production and Revenue by Type (2015-2026)
3.4 Asia Antibody Drug Conjugate Production and Revenue by Type (2015-2026)
3.5 Europe Antibody Drug Conjugate Production and Revenue by Type (2015-2026)
3.6 Middle East & Africa Antibody Drug Conjugate Production and Revenue by Type (2015-2026)
3.7 South America Antibody Drug Conjugate Production and Revenue by Type (2015-2026)
4 Global Antibody Drug Conjugate Market Assessment by Application
4.1 Historical & Forecast Global Antibody Drug Conjugate Consumption, Different Application Field (2015-2026)
4.2 Historical & Forecast North America Antibody Drug Conjugate Consumption, Different Application Field (2015-2026)
4.3 Historical & Forecast Asia Antibody Drug Conjugate Consumption, Different Application Field (2015-2026)
4.4 Historical & Forecast Europe Antibody Drug Conjugate Consumption, Different Application Field (2015-2026)
4.5 Historical & Forecast Middle East & Africa Antibody Drug Conjugate Consumption, Different Application Field (2015-2026)
4.6 Historical & Forecast South America Antibody Drug Conjugate Consumption, Different Application Field (2015-2026)
5 North America
5.1 US Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.2 Canada Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.3 Mexico Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
6.1 China Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.2 Japan Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.3 India Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.4 Korea Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.5 Southeat Asia Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
7.1 Germany Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.2 UK Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.3 France Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.4 Russia Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.5 Italy Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
8.1 Saudi Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.2 UAE Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.3 Egypt Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.4 Nigeria Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.5 South Africa Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
9.1 Brazil Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.2 Argentina Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.3 Colombia Antibody Drug Conjugate Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Antibody Drug Conjugate Average Price Trend
10.1 Market Price for Each Type of Antibody Drug Conjugate in North America (2015-2026)
10.2 Market Price for Each Type of Antibody Drug Conjugate in Asia (2015-2026)
10.3 Market Price for Each Type of Antibody Drug Conjugate in Europe (2015-2026)
10.4 Market Price for Each Type of Antibody Drug Conjugate in Middle East & Africa (2015-2026)
10.5 Market Price for Each Type of Antibody Drug Conjugate in South America (2015-2026)
11 Value Chain (Impact of COVID-19)
11.1 Antibody Drug Conjugate Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Antibody Drug Conjugate Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Antibody Drug Conjugate Competitive Analysis
12.1 Bayer AG
12.1.1 Bayer AG Company Profiles
12.1.2 Bayer AG Product Introduction
12.1.3 Bayer AG Antibody Drug Conjugate Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Concortis Biotherapeutics
12.2.1 Concortis Biotherapeutics Company Profiles
12.2.2 Concortis Biotherapeutics Product Introduction
12.2.3 Concortis Biotherapeutics Antibody Drug Conjugate Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 F. Hoffman-La Roche Ltd.
12.3.1 F. Hoffman-La Roche Ltd. Company Profiles
12.3.2 F. Hoffman-La Roche Ltd. Product Introduction
12.3.3 F. Hoffman-La Roche Ltd. Antibody Drug Conjugate Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 Immunomedics, Inc.
12.4.1 Immunomedics, Inc. Company Profiles
12.4.2 Immunomedics, Inc. Product Introduction
12.4.3 Immunomedics, Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 Abbvie Inc.
12.5.1 Oxford BioTherapeutics Company Profiles
12.5.2 Oxford BioTherapeutics Product Introduction
12.5.3 Oxford BioTherapeutics Antibody Drug Conjugate Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 Pfizer Inc.
12.6.1 Pfizer Inc. Company Profiles
12.6.2 Pfizer Inc. Product Introduction
12.6.3 Pfizer Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Seattle Genetics, Inc.
12.7.1 Seattle Genetics, Inc. Company Profiles
12.7.2 Seattle Genetics, Inc. Product Introduction
12.7.3 Seattle Genetics, Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Takeda Pharmaceutical Company Limited
12.8.1 Takeda Pharmaceutical Company Limited Company Profiles
12.8.2 Takeda Pharmaceutical Company Limited Product Introduction
12.8.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 Abbvie Inc.
12.9.1 Abbvie Inc. Company Profiles
12.9.2 Abbvie Inc. Product Introduction
12.9.3 Abbvie Inc. Antibody Drug Conjugate Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Astellas Pharma/Agensys
12.10.1 Astellas Pharma/Agensys Company Profiles
12.10.2 Astellas Pharma/Agensys Product Introduction
12.10.3 Astellas Pharma/Agensys Antibody Drug Conjugate Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
12.11 Oxford BioTherapeutics
12.12 Agensys, Inc.
12.13 Antikor
12.14 Celldex Therapeutics
12.15 Genentech
12.16 Heidelberg Pharma
12.17 Immunomedics
12.18 Mersana Therapeutics
12.19 Millennium Pharmaceuticals
12.20 Progenics Pharmaceuticals
12.21 Roche Holding Ag
12.22 Synthon
13 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
